Vikas Lifecare Gets Favorable Arbitration Order in Its Dispute With Eraaya Lifesciences

Mumbai, 17 July 2025: Vikas Lifecare Limited (NSE: VIKASLIFE, BSE: 542655) informed the exchanges today that it has won an arbitration award in its favor. The award pertains to its dispute in with Eraaya Lifespaces, with regard to the acquisition of Ebix. The arbitration order came on July 8th.

As of 9:35 AM IST, Vikas Lifecare Ltd. stock was trading flat at ₹2.55.

Arbitration Ruling Brings Closure to High-Stakes Investment Dispute

The legal dispute was initiated earlier this year when Eraaya Lifespaces Ltd. failed to return Vikas Lifecare’s investment amount within the agreed-upon timeline. This non-repayment led Vikas Lifecare to seek arbitration, resulting in a decision delivered on 8 July 2025 by Hon’ble Mr. Justice Vinod Goel (Retd.), former Judge of the Delhi High Court. The award marks a critical development in protecting investor rights in consortium-led international transactions.

Investment Deal Signed in May 2024; Non-Repayment Sparked Legal Action

On 24 May 2024, Vikas Lifecare entered into a consortium agreement with Eraaya Lifespaces Ltd. to jointly acquire Ebix Inc., a U.S.-based company undergoing Chapter 11 bankruptcy proceedings. Vikas Lifecare contributed $34.827 million as part of the consortium’s total bid. While the acquisition was officially completed on 30 August 2024, Eraaya failed to return the investment amount to Vikas Lifecare.

According to the company, the delay in repayment was attributed to a hold-up in the release of $40 million in Foreign Currency Convertible Bond (FCCB) proceeds by financial intermediaries. This unresolved delay forced Vikas Lifecare to initiate arbitration proceedings, which were disclosed publicly in February 2025.

Arbitration Outcome Marks a Win for Corporate Governance and Financial Prudence

The arbitration award issued by Justice Goel and received by Vikas Lifecare on 16 July 2025 signifies a positive resolution for the company. It also serves as a precedent for enforcing timely obligations in consortium-led international deals and reinforces trust in the arbitration system for corporate redressal.

Key Case Highlights

• Arbitration Authority: Hon’ble Mr. Justice Vinod Goel (Retd.), Ex-Judge, Delhi High Court
• Investment Amount: USD 34.827 million
• Agreement Date: 24 May 2024
• Acquisition Completion: 30 August 2024
• Arbitration Award Date: 8 July 2025
• Order Receipt Date: 16 July 2025
• Violations or Penalties: Not Applicable

Vikas Lifecare Continues Strategic Growth Across Key Sectors

Vikas Lifecare Limited is a publicly listed entity on both the NSE and BSE. The company operates across diverse sectors, including polymers, infrastructure, fast-moving consumer goods (FMCG), and sustainable technologies. With manufacturing units located in Rajasthan and Karnataka, the company continues to pursue aggressive expansion through calculated investments and strategic collaborations.

This recent arbitration win adds momentum to Vikas Lifecare’s ongoing efforts to strengthen its presence in high-growth sectors while ensuring financial discipline and investor accountability.

REF: https://nsearchives.nseindia.com/corporate/VIKASLIFE_16072025220500_VLL_Reg_30_-16072025.pdf

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations